InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Generics discuss fallout from major pharma patent cases

Ellie Mertens, New York

In-house counsel at global generic pharmaceutical companies point to Supernus, Novartis v Ezra and Helsinn as practically-important rulings for generics

Generic companies’ entire business relies on brands’ patents expiring, so anything that could delay pharmaceutical patents’ expiration is of acute interest to generics.

In its January 23 Supernus v Iancu decision, the Federal Circuit found that the USPTO’s patent term...

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog

null null null

null null null


September / October 2019

Should I stay or should I go? Private practice v in-house

In-house or private practice? It’s a question many lawyers and attorneys will probably ask themselves at some stage in their career, as Managing IP finds out

Most read articles